1
0
0
News
Netzwerk-Profile
LinkedIn: Hakim Echchannaoui | Berufsprofil - LinkedIn
weltweit größten beruflichen Netzwerk. Hakim Echchannaoui hat 1 Job im Profil
angegeben. Sehen Sie sich auf LinkedIn das vollständige Profil an und erfahren
Sie mehr über die Kontakte von Hakim Echchannaoui und über Jobs bei
ähnlichen ...
LinkedIn: Hakim Echchannaoui - 博士后- Johannes Gutenberg-Universität ...
上领英,在全球领先职业社交平台查看Hakim Echchannaoui的职业档案。Hakim的职业档案列出了1 个职位。查看Hakim的完整档案,结识职场人脉和查看相似公司的职位。
LinkedIn: Hakim Echchannaoui - Post-Doc - Johannes Gutenberg LinkedIn
Germany - Post-Doc - Johannes Gutenberg-Universität, Mainz#####View Hakim Echchannaoui's profile on LinkedIn, the world's largest professional community. Hakim has 1 job listed on their profile. See the complete profile on LinkedIn and discover Hakim's connections and jobs at similar companies.
Hakim Echchannaoui: مفت ڈاؤنلوڈ. ای بک لائبریری۔ Z-Library پر آن ...ur.booksc.me › author
ur.booksc.me
Hakim Echchannaoui: مفت ڈاؤنلوڈ. ای بک لائبریری۔ Z-Library پر آن لائن کتابوں کی دکانیں | BookSC. Download books for free. Find books.
Business-Profile
Hakim ECHCHANNAOUI | Universitätsmedizin der Johannes Gutenberg...
www.researchgate.net
Hakim Echchannaoui Markus Munder Interfering with tumor metabolism by specifically restricting the availability of extracellular nutrients is a rapidly emerging field of cancer research.
Bücher
Immune Therapy of Lympho-Hemopoietic Malignancies ...ur.booksc.eu › book
ur.booksc.eu
Immune Therapy of Lympho-Hemopoietic Malignancies Hakim Echchannaoui a, b Matthias Theobald a, b a University Cancer Center (UCT), Research Center ...
p53 in the Clinicsbooks.google.com › books
books.google.com
Immunotherapy. of. Cancer. Hakim Echchannaoui and Matthias Theobald. 1. p53: Guardian. of. the. Genome. Cancer is usually associated with deregulated cell ...
Dokumente zum Namen
Echchannaoui, Hakim [WorldCat Identities]worldcat.org › identities
worldcat.org
Most widely held works by Hakim Echchannaoui ... Immune Therapy of Lympho-Hemopoietic Malignancies by Hakim Echchannaoui( )
[PDF] ZORA_NL_ pdfwww.zora.uzh.ch › eprint › ZORA_NL_
www.zora.uzh.ch
Hakim Echchannaoui,1 Karl Frei,3 Christian Schnell,2. Stephen L. Leib,4 Werner Zimmerli,1 and Regine Landmann1. 1Division of Infectious Diseases, ...
Wissenschaftliche Veröffentlichungen
Toll-Like Receptor 2-Deficient Mice Are Highly Susceptible to jstorwww.jstor.org › stable
www.jstor.org
Hakim Echchannaoui,1 Karl Frei,3 Christian Schnell,2. Stephen L. Leib,4 Werner Zimmerli,1 and Regine Landmann1. 1 Division of Infectious Diseases, ...
Veröffentlichungen allgemein
[PDF] pdf - COREcore.ac.uk › download › pdf
core.ac.uk
Vorgelegt der. Philosophisch-Naturwissenschaftlichen Fakultät der Universität Basel von. Hakim Echchannaoui aus Saint-Louis, Frankreich. Basel, August
[PDF] Abstracts BOOK - American Association for Cancer Research (AACR)www.aacr.org › uploads › › Abstract-book-FINAL1
www.aacr.org
Site Frankfurt/Mainz, Germany), Hakim Echchannaoui (Internal. Medicine III, University Cancer Center (UCT), Research Center.
Sonstiges
EP B1 - Nouveaux antigènes associés aux tumeurs ...patents.google.com › patent
patents.google.com
... Fatho: Daniela Eberts: Hakim ECHCHANNAOUI: Volker Lennerz: Catherine WÖLFEL: Thomas Wölfel; Current Assignee (The listed assignees may be inaccurate.
III. Medizinische Klinik - Arbeitsgruppe Echchannaoui/Theobald |...
www.unimedizin-mainz.de
Principal Investigators. Dr. phil. nat. Hakim Echchannaoui. Funktionen: Senior Research Scientist Kontakt aufnehmen. Univ.-Prof. Dr. med. Matthias Theobald. Funktionen: Director of the Department of Hematology, Oncology, and Pneumology, Deputy director of the University Cancer Center Mainz (UCT Mainz)
616. Acute Myeloid Leukemias: Investigational Therapies, Excluding ...ash.confex.com › ash › webprogram › Session22807
ash.confex.com
... Catharina Lahrmann1*, Kerstin Kunz1*, Linda Kessler, BA3*, Hakim Echchannaoui, PhD1*, Chun-Wei David Chen, PhD4, Thomas Kindler, MD5*, Francis Burrows, ...
Adoptiver Immuntransfer und CAR-T-Zellen bei malignen ...www.semanticscholar.org › paper › Adoptiver-Imm...
www.semanticscholar.org
Hakim Echchannaoui, K. Dietrich, M. Theobald; Published 21 August 2017; Medicine; Der Onkologe. ZusammenfassungHintergrundDie adoptive Zelltherapie (ACT) ...
Investigating T Cell Immunity in Cancer: Achievements and Prospectswww.mdpi.com › review_report
www.mdpi.com
Reviewer 2: Hakim Echchannaoui. Int. J. Mol. Sci , 22(6), 2907; https://doi.org ijms Received: 19 January Revised: 4 March
The Interleukin-10 Signal Transduction Pathway and Regulation of ...www.liebertpub.com › doi › pdfplus
www.liebertpub.com
Maryse Letiembre, Hakim Echchannaoui, Fabrizia Ferracin, Serge Rivest, Regine Landmann Toll- like receptor-2 deficiency is associated with enhanced ...
The Δ133p53 Isoforms, Tuners of the p53 Pathway - OUCIouci.dntb.gov.ua › works
ouci.dntb.gov.ua
... Danuta Galetzka, Borhane Guezguez, Michael Hundemer, Jean-Christophe Bourdon, Markus Munder, Matthias Theobald, Hakim Echchannaoui.
Toll-Like Receptor 2 Deficiency Delays ASM Journalsjournals.asm.org › ... › Vol. 73, No. 12
journals.asm.org
Authors: Maryse Letiembre, Hakim Echchannaoui, Philipp Bachmann, Fabrizia Ferracin, Concepción Nieto, Manuel Espinosa, Regine Landmann [email ...
Toll-Like Receptor 2 Deficiency Delays Pneumococcal Phagocytosis ...www.academia.edu › Toll_Like_Receptor_2_Defici...
www.academia.edu
Toll-Like Receptor 2 Deficiency Delays Pneumococcal Phagocytosis and Impairs Oxidative Killing by Granulocytes Maryse Letiembre,1† Hakim Echchannaoui,1† ...
Western blotting —Bio-101cn.bio-protocol.org › bio101
cn.bio-protocol.org
... Borhane Guezguez MH Michael Hundemer JB Jean-Christophe Bourdon MM Markus Munder MT Matthias Theobald HE Hakim Echchannaoui. 本实验方法提取自研究论文:
[PPT]
www.jni-journal.com
Maryse Letiembre, Hakim Echchannaoui, Fabrizia Ferracin, Serge Rivest, Regine Landmann. Journal of Neuroimmunology. Volume 168 Issue 1 Pages (November ...
ijms xml - MDPImdpi-res.com › d_attachment › ijms › ijms › article_deploy › ij...
mdpi-res.com
... Soo Seo Shilpa Singh Hakim Echchannaoui Shilpa Thakur Halil İbrahim Çiftçi Shimeles Tilahun Hamid Badali Shimi Meleppattu Hamid Maadi Shimpei Higo Hamza ...
p53-specific T cell receptor - [scite report]scite.ai › reports
scite.ai
A Potent Tumor-Reactive p53-Specific Single-Chain TCR without On- or Off-Target Autoimmunity In Vivo · Hakim Echchannaoui 1,. Jutta Petschenka.
Association cantonale vaudoise de football - Match center - SFVmatchcenter-acvf.football.ch › ...
matchcenter-acvf.football.ch
· Hakim Echchannaoui ? 12. Essaid Tamtam ? Remplaçants Donato Stefanelli. 7. Edouard Demont. 9. Kais Roger Riahi. 4. Nenad Berbatovic.
Cited By Cancer Research and Treatmentwww.e-crt.org › journal › CitedBy
www.e-crt.org
· Anke Werner, Daniel Pieh, Hakim Echchannaoui, Johanna Rupp, Krishnaraj Rajalingam, Matthias Theobald, Ellen I. Closs, Markus Munder.
LFA-1 on CD4+ T Cells Is Required for Optimal Antigen-Dependent ...www.jimmunol.org › content › tab-article-info
www.jimmunol.org
· Julian Plaumann, Melanie Engelhardt, Mohamed H. S. Awwad, Hakim Echchannaoui, Eva Amman, Marc S. Raab, Jens Hillengass, Niels Halama, ...
Verwandte Suchanfragen zu Hakim Echchannaoui
Regine Landmann Daniel Pieh Anke Werner | Johanna Rupp |
Personen Vorname "Hakim" (734) Name "Echchannaoui" (1) |
sortiert nach Relevanz / Datum